Deciphera Pharmaceuticals
AcquiredUnited States · $142.0M raised
- Business Model
- B2B
- Website
- deciphera.com
- Total Funding
- $142.0M
- Last Round
- $52.0M Series CJun 2017
- Rounds
- 2
About
Biopharmaceutical company developing innovative medicines for cancer using switch-control kinase inhibitor platform.
Summary
Deciphera Pharmaceuticals is a Biotech company based in United States. It has raised $142.0M in total across 2 rounds, most recently a $52.0M Series C round in Jun 2017. Investors include Ono Pharmaceutical, SV Life Sciences and Viking Global.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Apr 2024
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...